You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

Article metrics

Article menu

Download PDFPDF

Infections
Original research
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

 

Online download statistics by month:

Online download statistics by month: October 2021 to September 2024

AbstractFullPdf
Oct 2021668666119
Nov 2021652650122
Dec 202132331751
Jan 202226125161
Feb 202218018468
Mar 202219618831
Apr 202222422434
May 202221321555
Jun 202218418164
Jul 202213212940
Aug 202213813741
Sep 202217817346
Oct 202214914636
Nov 202212512232
Dec 20221031006
Jan 202312512117
Feb 202310710525
Mar 2023827720
Apr 2023636018
May 2023717020
Jun 2023676612
Jul 2023696211
Aug 2023575612
Sep 202347473
Oct 2023625516
Nov 202376702
Dec 2023737217
Jan 202467628
Feb 2024585515
Mar 2024636060
Apr 2024575432
May 2024615710
Jun 2024636113
Jul 20241028718
Aug 202468657
Sep 2024615910
Total522551041152